← Back
$BOLT All transactions

Bolt Biotherapeutics, Inc.

A

$ Value

$0

Shares

1,100

Price

$0

Filed

Jul 2

Insider

Name

LAPORTE KATHLEEN

Title

CIK

0001196201

Roles

Director

Transaction Details

Transaction Date

2025-05-27

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,100

Footnotes

On June 6, 2025, the Company effected a 1-for-20 reverse stock split of its common stock. All share and exercise price amounts reported herein reflect the reverse stock split. Prior to the reverse stock split, the reporting person was granted options to purchase 22,000 shares at an exercise price of $0.3200 per share. | The shares subject to the option will vest on the earlier of May 27, 2026 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer.

Filing Info

Accession No.

0000950170-25-092938

Form Type

4

Issuer CIK

0001641281

LAPORTE KATHLEEN's History

Date Ticker Type Value
2026-01-15 PRPO A $12K
2026-01-15 QTTB A $64K
2026-01-07 CERO A $0
2026-01-02 PRPO A $0
2025-12-12 BOLT A
2025-12-12 BOLT D
2025-12-12 BOLT A
2025-12-12 BOLT D
2025-12-12 BOLT A
2025-12-12 BOLT D

Other Insiders at BOLT (90d)

Insider Bought Sold Last
Quinn William P.
President, CEO and CFO
$576 2026-01-28
Nemec Sarah
Senior VP, Finance and PAO
$576 2026-01-28
Yonehiro Grant
Chief Operating Officer
2026-01-28